We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$20.3B
AUM Growth
-$658M
Cap. Flow
-$389M
Cap. Flow %
-1.92%
Top 10 Hldgs %
19.94%
Holding
3,276
New
193
Increased
1,504
Reduced
1,271
Closed
193

Sector Composition

Rank Sector Weight
1 Technology 9.58%
2 Consumer Discretionary 4.97%
3 Financials 4.87%
4 Healthcare 3.87%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DWLD icon
2601
Davis Select Worldwide ETF
DWLD
$610M
$254K ﹤0.01%
8,553
ECF
2602
Ellsworth Growth & Income Fund
ECF
$178M
$254K ﹤0.01%
19,022
+3,833
+25% +$55.6K
HQL
2603
abrdn Life Sciences Investors
HQL
$646M
$254K ﹤0.01%
12,212
+404
+3% +$8.65K
MILN
2604
Global X Millennial Consumer ETF
MILN
$102M
$254K ﹤0.01%
5,911
+651
+12% +$28.7K
SRET icon
2605
Global X SuperDividend REIT ETF
SRET
$229M
$254K ﹤0.01%
8,913
+28
+0.3% +$819
SHYM
2606
iShares Short Duration High Yield Muni Active ETF
SHYM
$816M
$254K ﹤0.01%
+9,608
New +$257K
CNQ icon
2607
Canadian Natural Resources
CNQ
$98.1B
$253K ﹤0.01%
+14,157
New +$233K
DEI icon
2608
Douglas Emmett
DEI
$1.95B
$253K ﹤0.01%
8,014
+63
+0.8% +$2.08K
MVT
2609
DELISTED
BlackRock MuniVest Fund II
MVT
$253K ﹤0.01%
16,655
RDFN
2610
DELISTED
Redfin
RDFN
$253K ﹤0.01%
5,054
-196
-4% -$10.6K
VIRS
2611
DELISTED
Pacer BioThreat Strategy ETF
VIRS
$253K ﹤0.01%
7,779
+1
+0% +$33
DMTK
2612
DELISTED
DermTech, Inc. Common Stock
DMTK
$253K ﹤0.01%
7,892
+1,981
+34% +$69.6K
KRTX
2613
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$253K ﹤0.01%
2,067
+15
+0.7% +$1.73K
SOLN
2614
DELISTED
The Southern Company
SOLN
$253K ﹤0.01%
4,965
BSCS icon
2615
Invesco BulletShares 2028 Corporate Bond ETF
BSCS
$3.59B
$252K ﹤0.01%
11,004
-58
-0.5% -$1.34K
CDK
2616
DELISTED
CDK Global, Inc.
CDK
$252K ﹤0.01%
5,927
-1,105
-16% -$49.8K
ACM icon
2617
Aecom
ACM
$7.86B
$251K ﹤0.01%
3,981
+200
+5% +$12.7K
TDF
2618
Templeton Dragon Fund
TDF
$274M
$251K ﹤0.01%
13,985
+945
+7% +$19.5K
NEE.PRQ
2619
DELISTED
NextEra Energy, Inc. 6.219% Corporate Units
NEE.PRQ
$251K ﹤0.01%
4,910
+105
+2% +$5.54K
AIT icon
2620
Applied Industrial Technologies
AIT
$13B
$249K ﹤0.01%
2,763
+63
+2% +$5.54K
CCK icon
2621
Crown Holdings
CCK
$13.1B
$249K ﹤0.01%
+2,470
New +$259K
SLCA
2622
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$249K ﹤0.01%
31,152
-520
-2% -$4.92K
GCC icon
2623
WisdomTree Enhanced Commodity Strategy Fund
GCC
$282M
$248K ﹤0.01%
11,140
+288
+3% +$6.34K
UTRN
2624
DELISTED
Vesper US Large Cap Short-Term Reversal Strategy ETF
UTRN
$248K ﹤0.01%
+7,212
New +$254K
FTDS icon
2625
First Trust Dividend Strength ETF
FTDS
$39.6M
$247K ﹤0.01%
+5,236
New +$253K

Similar funds

Cambridge Investment Research Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Cambridge Investment Research Advisors held 3,276 positions worth $20.3B, down 3.1% from $20.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q3 2021 filing shows 193 new, 1,504 increased, 1,271 reduced and 193 closed positions. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 269,623 shares worth $6.98M. The largest sale was iShares S&P 500 Growth ETF, an estimated $90.8M.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.3% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Cambridge Investment Research Advisors's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 269,623 shares worth $6.98M.
  • Cambridge Investment Research Advisors added most to iShares Core S&P US Growth ETF in Q3 2021, an estimated $42.5M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2021 reduction was iShares S&P 500 Growth ETF, cutting an estimated $90.8M.
  • Cambridge Investment Research Advisors fully exited VanEck Steel ETF in Q3 2021, selling an estimated $6.22M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $20.3B portfolio in Q3 2021.
  • Cambridge Investment Research Advisors opened 193 new positions and closed 193 in Q3 2021.
  • Cambridge Investment Research Advisors's portfolio value fell 3.1% quarter-over-quarter to $20.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.